Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. - Wikidata - wikimedia - TriplyDB

Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications.

Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications.

http://www.wikidata.org/entity/Q37944058

about

Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors The lysosome: from waste bag to potential therapeutic target Circulating Anti-Elastin Antibody Levels and Arterial Disease Characteristics: Associations with Arterial Stiffness and Atherosclerosis Novel biological markers of bone: from bone metabolism to bone physiology Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury Increased serum cathepsin K in patients with coronary artery disease.Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat Vasculature.Serum cystatin C is a determinant of central pressure augmentation index measured by oscillometric method in renal transplant recipients Urotensin II promotes atherosclerosis in cholesterol-fed rabbits.Cathepsin K-mediated Notch1 activation contributes to neovascularization in response to hypoxia.Increased Circulating Cathepsin K in Patients with Chronic Heart Failure Increased Plasma Dipeptidyl Peptidase-4 Activities in Patients with Coronary Artery Disease.Increased Infiltration of Extra-Cardiac Cells in Myxomatous Valve Disease.Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease.Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms.Mechanisms with clinical implications for atrial fibrillation-associated remodeling: cathepsin K expression, regulation, and therapeutic target and biomarker.Cysteine protease inhibition by nitrile-based inhibitors: a computational study.Mast cell chymase and tryptase in abdominal aortic aneurysm formation.Odanacatib for the treatment of osteoporosis.Cathepsin L activity correlates with proteinuria in chronic kidney disease in humans.Insights from molecular modeling into the selective inhibition of cathepsin S by its inhibitor.MicroRNA regulation of extracellular matrix components in the process of atherosclerotic plaque destabilization.Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.Cystatin C, chronic kidney disease and retinopathy in adults without diabetes.Changes in Structural-Mechanical Properties and Degradability of Collagen during Aging-associated Modifications Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients.Cathepsin K activity controls injury-related vascular repair in mice.Decreased cathepsin K levels in human atherosclerotic plaques are associated with plaque instability.A possible role of cystatin C in adipose tissue homeostasis may impact kidney function estimation in metabolic syndrome.Cathepsin K activity controls cardiotoxin-induced skeletal muscle repair in mice.Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases.Cathepsin S As an Inhibitor of Cardiovascular Inflammation and Calcification in Chronic Kidney Disease.Impact of circulating cathepsin K on the coronary calcification and the clinical outcome in chronic kidney disease patients.Genome-wide differential expression profiling of mRNAs and lncRNAs associated with prolificacy in Hu sheep.Differential hypertensive protease expression in the thoracic versus abdominal aorta.Live Cell Imaging and Profiling of Cysteine Cathepsin Activity Using a Quenched Activity-Based Probe.Dilating Vascular Diseases: Pathophysiology and Clinical Aspects Investigating potential mediator between statin and coronary artery calcification Comparison of Different Measures of Fat Mass and Their Association with Serum Cystatin C Levels

P2860

Q26771736-0600F694-03E2-43A0-A955-239689516A1E Q27022248-E1A2D2ED-B4E3-4EC0-99E4-60F733A90D09 Q27333137-3C52FA95-7798-4C46-90D8-572E265CE62D Q28067712-1370602E-D5A4-4D7C-B9AF-9104D7D04805 Q33789216-49ABA52E-E701-43BE-8555-9883DEEB959B Q33822554-4237ADC9-4898-424D-AD00-DD8811B448AB Q34542663-5D2E3B49-EB3C-4971-A8F9-0B9609D561BD Q34940161-3E633583-62A7-4B44-8932-88265D13B6C6 Q35152923-0BCC043A-8EBC-41A2-BF76-0F7B18A78531 Q35181072-71B2390A-C667-4C94-B6DC-7FC6797B3EBC Q35753850-9922823A-818B-44B0-B2B7-5982ABD1189A Q36139664-806302A7-4E67-4E67-BCBE-7865E2FCBACE Q36155598-DAD24A95-AFD1-4668-9467-0855BDB45796 Q36211889-D3C18380-6FA7-4EA8-8AD6-D060950B0288 Q36599238-99FC9D2A-7E84-425C-98E3-EE50B7A3C09F Q37457719-2B6A844F-0BAC-42A1-9E72-AE71C022D5BF Q37696070-51F22359-2F1C-4F91-896C-5153B6B004F6 Q38035575-85D3BBAD-07B7-4423-AEB1-99493F525D22 Q38543387-418AE871-50E4-4167-BEC8-18A7C8617810 Q38680372-8D0C2469-64B9-4ECE-8FED-A9999F63067F Q38943054-D8F87F17-2961-4D01-996E-63FC0D3C4BBB Q39261257-3E182F8C-16F4-48DA-AC7E-5FD65E5F1475 Q39640572-CDC4BA8E-1124-494D-8E74-CC7114FB18ED Q40322521-68CC7990-FB74-455A-9F04-5467A28215DB Q40356301-39032FEB-F375-4F32-B0F8-D91CDA9DAA0D Q40679886-9FE5770F-64F3-4A4B-97E5-7B274718AD8B Q41468695-9DACA2F0-DD7B-4F1B-B6A9-B18BDAA7171F Q41769190-E901CC85-A1DE-4801-B906-DAB00B62D885 Q42376295-AC476447-5021-4F6C-85F4-21BF43F3F6A4 Q45236215-12AF9491-B2D3-4655-9427-CF61F4824D46 Q47616758-0C3775C8-F1BD-4E16-B010-9EA1734D1934 Q47696129-957A5AEC-D5E2-4A62-A194-99126763933F Q47696609-6893B6D0-14CF-4999-A662-5684A349D368 Q48588869-3FD900D6-596C-465B-9811-5CEC4850B242 Q50035213-CEF6244F-F180-4978-8C91-043E00FC6BFA Q50982477-8A1BFA84-7585-4273-91EA-A2FA4239A693 Q52864120-77825FB2-67D6-48CC-9007-B85F5F63B0E8 Q58702250-C19FDCBC-AA34-4F4C-A869-67009896D41A Q58727283-959B111A-0C34-40CE-9025-36BEAD337A0D Q59050709-9B1B9E9A-B41E-4480-9234-F52326BF6A16

P2860

Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications.

http://www.wikidata.org/entity/Q37944058

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cysteine protease cathepsins i ...... disease and its complications.

@en

Cysteine protease cathepsins i ...... disease and its complications.

@nl

type

label

Cysteine protease cathepsins i ...... disease and its complications.

@en

Cysteine protease cathepsins i ...... disease and its complications.

@nl

prefLabel

Cysteine protease cathepsins i ...... disease and its complications.

@en

Cysteine protease cathepsins i ...... disease and its complications.

@nl

P1433

Q37944058-893BA1F7-A2D6-4B17-85C9-F1A234DEE7B6

P1476

Q37944058-01BF4C9C-0C23-443D-B32F-F2B5A73D60F5

P2093

Q37944058-037E4FE6-CB68-4E32-9AAB-B7D60C757995

Q37944058-48FE6968-C1C7-4C3B-AE90-CDBB572B9B2F

Q37944058-AAC51FCF-D709-4EE4-BDD2-FEEC06C019EB

Q37944058-D67A1178-2C64-46D5-9672-947F2628BA47

Q37944058-DA381745-6010-4E59-9644-802CE259F1BB

P304

Q37944058-A3F135D5-FFE5-4D21-ABD9-00736A05112D

P31

Q37944058-7307A848-75A5-4182-99E6-41AE4AF91374

P356

Q37944058-FB882E6D-B7FE-464E-B368-8193E37A723A

P407

Q37944058-8DB34CBC-55BE-42D0-818D-51C5A1E80F1B

P433

Q37944058-87667B2C-C167-44D1-AB74-B84725F56675

P478

Q37944058-3E7270E5-2A4D-426A-8C86-3B3C68D87793

P577

Q37944058-C4A44ECE-182E-47AB-AD4C-320D62957DBA

P5875

Q37944058-A4C84BEC-6E3C-4667-9B6D-6ABD7DF76B44

P698

Q37944058-F01BB8E8-6131-4EEB-B01A-69DA6986BC3E

P921

Q37944058-972A18AD-FE70-4872-A15C-407BF1FE1060

P356

HYPERTENSIONAHA.111.180935

P1433

P1476

Cysteine protease cathepsins i ...... disease and its complications.

@en

P2093

Kenji Okumura

http://www.w3.org/2001/XMLSchema#string

Masafumi Kuzuya

http://www.w3.org/2001/XMLSchema#string

Toyoaki Murohara

http://www.w3.org/2001/XMLSchema#string

Xian Wu Cheng

http://www.w3.org/2001/XMLSchema#string

Zhe Huang

http://www.w3.org/2001/XMLSchema#string

P304

978-986

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.111.180935

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51706124

http://www.w3.org/2001/XMLSchema#string

P698

21986502

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis